Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data

Author:

Muntner Paul1ORCID,Hernandez Rohini K.2,Kent Shia T.2,Browning James E.2,Gilbertson David T.3,Hurwitz Kathleen E.4,Jick Susan S.5ORCID,Lai Edward C.6ORCID,Lash Timothy L.7,Monda Keri L.2,Rothman Kenneth J.89,Bradbury Brian D.2,Brookhart M. Alan10

Affiliation:

1. Department of Epidemiology, School of Public Health University of Alabama at Birmingham Birmingham Alabama USA

2. Center for Observational Research Amgen Inc. Thousand Oaks California USA

3. Chronic Disease Research Group Hennepin Healthcare Research Institute Minneapolis Minnesota USA

4. Target RWE Durham North Carolina USA

5. Boston Collaborative Drug Surveillance Program Boston University School of Public Health Boston Massachusetts USA

6. School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine National Cheng Kung University Tainan Taiwan

7. Department of Epidemiology, Rollins School of Public Health Emory University Atlanta Georgia USA

8. RTI Health Solutions, Research Triangle Institute Research Triangle Park North Carolina USA

9. Department of Epidemiology Boston University School of Public Health Boston Massachusetts USA

10. Department of Population Health Sciences Duke University Durham North Carolina USA

Abstract

AbstractPurposeWe describe constructs designed to protect the integrity of the results from comparative analyses using real‐world data (RWD): staging and clean room.MethodsStaging involves performing sequential preliminary analyses and evaluating the population size available and potential bias before conducting comparative analyses. A clean room involves restricted access to data and preliminary results, policies governing exploratory analyses and protocol deviations, and audit trail. These constructs are intended to allow decisions about protocol deviations, such as changes to design or model specification, to be made without knowledge of how they might affect subsequent analyses. We describe an example for implementing staging with a clean room.ResultsStage 1 may involve selecting a data source, developing and registering a protocol, establishing a clean room, and applying inclusion/exclusion criteria. Stage 2 may involve attempting to achieve covariate balance, often through propensity score models. Stage 3 may involve evaluating the presence of residual confounding using negative control outcomes. After each stage, check points may be implemented when a team of statisticians, epidemiologists and clinicians masked to how their decisions may affect study outcomes, reviews the results. This review team may be tasked with making recommendations for protocol deviations to address study precision or bias. They may recommend proceeding to the next stage, conducting additional analyses to address bias, or terminating the study. Stage 4 may involve conducting the comparative analyses.ConclusionsThe staging and clean room constructs are intended to protect the integrity and enhance confidence in the results of analyses of RWD.

Funder

Amgen

Publisher

Wiley

Reference35 articles.

1. Food and Drug Administration.Framework for FDA's real‐world evidence program.2023Accessed April 30 2023.https://www.fda.gov/media/120060/download

2. The FDA's sentinel initiative-A comprehensive approach to medical product surveillance

3. Trial designs using real‐world data: The changing landscape of the regulatory approval process

4. Real-World Evidence — Where Are We Now?

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3